$APCX
AppTech Payments Corp. Stock $apcx

$apcx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000168316823008030 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$141.0K	$140.0K	$115.0K
YoY Change	30.56%	21.74%	24.45%
Cost Of Revenue	$28.00K	$44.00K	$54.00K
YoY Change	-47.17%	-18.52%	29.28%
Gross Profit	$113.0K	$96.00K	$61.00K
YoY Change	105.45%	57.38%	20.46%
Gross Profit Margin	80.14%	68.57%	53.04%
Selling, General & Admin	$2.759M	$2.230M	$1.365M
YoY Change	8.75%	63.37%	0.35%
% of Gross Profit	2441.59%	2322.92%	2237.7%
Research & Development	$724.0K	$751.0K	$1.513M
YoY Change	-64.12%	-50.36%
% of Gross Profit	640.71%	782.29%	2480.33%
Depreciation & Amortization	$275.0K	$120.0K
YoY Change	-32.1%
% of Gross Profit	243.36%	125.0%
Operating Expenses	$3.483M	$2.978M	$2.878M
YoY Change	-23.53%	3.47%	17.43%
Operating Profit	-$3.370M	-$2.882M	-$2.817M
YoY Change	-25.11%	2.31%	17.36%
Interest Expense	-$4.000K	$0.00	$41.00K
YoY Change	-98.64%	-100.0%	-111.97%
% of Operating Profit
Other Income/Expense, Net	$4.000K	-$9.000K	-$32.00K
YoY Change	-88.57%	-71.88%	-20100.0%
Pretax Income	-$3.387M	-$2.891M	-$2.849M
YoY Change	-28.84%	1.47%	3.88%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.387M	-$2.891M	-$2.849M
YoY Change	-28.84%	1.47%	3.88%
Net Earnings / Revenue	-2402.13%	-2065.0%	-2477.39%
Basic Earnings Per Share		-$0.15	-$0.17
Diluted Earnings Per Share	-$0.16	-$0.15	-$171.7K
COMMON SHARES
Basic Shares Outstanding	20.69M shares	18.52M shares	16.56M shares
Diluted Shares Outstanding		18.80M shares	16.60M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.281M	$250.0K	$5.878M
YoY Change	-63.0%	-95.75%	26024.44%
Cash & Equivalents	$1.281M	$251.0K	$5.878M
Short-Term Investments
Other Short-Term Assets	$205.0K	$320.0K	$1.029M
YoY Change	-77.52%	-68.9%	1000.3%
Inventory
Prepaid Expenses	$205.0K	$324.0K	$370.0K
Receivables	$30.00K	$253.0K	$100.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.516M	$828.0K	$7.007M
YoY Change	34159.89%	-88.18%	4545.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$66.00K	$80.00K	$143.0K
YoY Change	-48.03%	-44.06%	-29.88%
Goodwill	$1.161M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.000K	$10.00K	$3.008M
YoY Change	-99.67%	-99.67%	9144.01%
Total Long-Term Assets	$6.837M	$1.615M	$8.772M
YoY Change	84369.98%	-81.59%	19.82%
TOTAL ASSETS
Total Short-Term Assets	$1.516M	$828.0K	$7.007M
Total Long-Term Assets	$6.837M	$1.615M	$8.772M
Total Assets	$8.353M	$2.443M	$15.78M
YoY Change	66622.58%	-84.52%	111.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.799M	$552.0K	$383.0K
YoY Change	518343.8%	44.13%	-77.9%
Accrued Expenses	$536.0K	$340.0K	$1.727M
YoY Change	28563.1%	-80.31%	-3.28%
Deferred Revenue
YoY Change
Short-Term Debt	$1.000K	$0.00	$1.122M
YoY Change	-99.94%	-100.0%	-35.35%
Long-Term Debt Due			$680.0K
YoY Change
Total Short-Term Liabilities	$4.080M	$1.528M	$4.824M
YoY Change	82675.41%	-68.33%	-21.9%
LONG-TERM LIABILITIES
Long-Term Debt	$65.00K	$70.00K	$67.00K
YoY Change	-2.99%	4.48%	-58.14%
Other Long-Term Liabilities	$14.00K	$30.00K	$115.0K
YoY Change	-85.86%	-73.91%	-40.78%
Total Long-Term Liabilities	$79.00K	$99.00K	$182.0K
YoY Change	47490.36%	-45.6%	-48.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.080M	$1.528M	$4.824M
Total Long-Term Liabilities	$79.00K	$99.00K	$182.0K
Total Liabilities	$4.159M	$1.627M	$5.006M
YoY Change	81529.05%	-67.5%	-23.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$159.7M	-$156.4M	-$135.7M
YoY Change	-113821.4%	15.21%
Common Stock	$22.00K	$19.00K	$16.00K
YoY Change	129311.76%	18.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.194M	$816.0K	$10.77M
YoY Change
Total Liabilities & Shareholders Equity	$8.353M	$2.443M	$15.78M
YoY Change	66622.58%	-84.52%	111.18%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$3.387M	-$2.891M	-$2.849M
YoY Change	-28.84%	1.47%	3.88%
Depreciation, Depletion And Amortization	$275.0K	$120.0K
YoY Change	-32.1%
Cash From Operating Activities	-$2.309M	-$1.130M	-$369.0K
YoY Change	-5.83%	206.23%	285.66%
INVESTING ACTIVITIES
Capital Expenditures	-$50.00K	$50.00K	-$1.563M
YoY Change	-221.95%	-103.2%	585.53%
Acquisitions
YoY Change
Other Investing Activities	-$500.0K
YoY Change	24900.0%
Cash From Investing Activities	-$450.0K	-$50.00K	-$1.563M
YoY Change	946.51%	-96.8%	562.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.798M	680.0K	20.00K
YoY Change	4707.59%	3300.0%
NET CHANGE
Cash From Operating Activities	-2.309M	-1.130M	-369.0K
Cash From Investing Activities	-450.0K	-50.00K	-1.563M
Cash From Financing Activities	3.798M	680.0K	20.00K
Net Change In Cash	1.039M	-500.0K	-1.912M
YoY Change	-143.0%	-73.85%	476.46%
FREE CASH FLOW
Cash From Operating Activities	-$2.309M	-$1.130M	-$369.0K
Capital Expenditures	-$50.00K	$50.00K	-$1.563M
Free Cash Flow	-$2.259M	-$1.180M	$1.194M
YoY Change	-9.39%	-198.83%	802.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001070050
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2774000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5539000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39158
	dei	Entity Registrant Name EntityRegistrantName	AppTech Payments Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	65-0847995
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5876 Owens Ave. Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carlsbad
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92008
	dei	City Area Code CityAreaCode	(760)
	dei	Local Phone Number LocalPhoneNumber	707-5959
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20690942	shares
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	251000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3462000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	253000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	324000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.81
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	99000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	183000	usd
CY2023Q3	apcx	Prepaid License Fees Current PrepaidLicenseFeesCurrent	0	usd
CY2022Q4	apcx	Prepaid License Fees Current PrepaidLicenseFeesCurrent	729000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	828000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4425000	usd
CY2023Q3	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	2700000	usd
CY2023Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	209000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	311000	usd
CY2023Q3	apcx	Note Receivable Current NoteReceivableCurrent	26000	usd
CY2022Q4	apcx	Note Receivable Current NoteReceivableCurrent	26000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	82000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127000	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9000	usd
CY2023Q3	apcx	Capitalized Software Development And License Net Of Accumulated Amortization CapitalizedSoftwareDevelopmentAndLicenseNetOfAccumulatedAmortization	1289000	usd
CY2022Q4	apcx	Capitalized Software Development And License Net Of Accumulated Amortization CapitalizedSoftwareDevelopmentAndLicenseNetOfAccumulatedAmortization	4921000	usd
CY2023Q3	us-gaap	Assets Assets	2443000	usd
CY2022Q4	us-gaap	Assets Assets	12519000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	552000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	347000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	340000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1870000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	78000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64000	usd
CY2023Q3	apcx	Stock Repurchase Liability StockRepurchaseLiability	0	usd
CY2022Q4	apcx	Stock Repurchase Liability StockRepurchaseLiability	430000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4000	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	676000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1021000	usd
CY2023Q3	apcx	Notes Payable Related Parties NotesPayableRelatedParties	0	usd
CY2022Q4	apcx	Notes Payable Related Parties NotesPayableRelatedParties	88000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	557000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	433000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1528000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4929000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	99000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	67000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	67000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	166000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1627000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5095000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10526	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10526	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	105263158	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	105263158	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19020008	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19020008	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16697280	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16697280	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	157159000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	147881000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-156362000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-140474000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	816000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7424000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2443000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12519000	usd
CY2023Q3	us-gaap	Revenues Revenues	140000	usd
CY2022Q3	us-gaap	Revenues Revenues	115000	usd
	us-gaap	Revenues Revenues	363000	usd
	us-gaap	Revenues Revenues	342000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	44000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	54000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	159000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	167000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	96000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	61000	usd
	us-gaap	Gross Profit GrossProfit	204000	usd
	us-gaap	Gross Profit GrossProfit	175000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2227000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1365000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7114000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5466000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	751000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1513000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2774000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5539000	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	6131000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q3	apcx	Excess Fair Value Of Equity Issuance Over Assets Received ExcessFairValueOfEquityIssuanceOverAssetsReceived	0	usd
CY2022Q3	apcx	Excess Fair Value Of Equity Issuance Over Assets Received ExcessFairValueOfEquityIssuanceOverAssetsReceived	0	usd
	apcx	Excess Fair Value Of Equity Issuance Over Assets Received ExcessFairValueOfEquityIssuanceOverAssetsReceived	0	usd
	apcx	Excess Fair Value Of Equity Issuance Over Assets Received ExcessFairValueOfEquityIssuanceOverAssetsReceived	904000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2978000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2878000	usd
	us-gaap	Operating Expenses OperatingExpenses	16019000	usd
	us-gaap	Operating Expenses OperatingExpenses	11909000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2882000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2817000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15815000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11734000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-41000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-48000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-137000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	8000	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	27000	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	181000	usd
CY2023Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5000	usd
CY2022Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	711000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	169000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-32000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	690000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	213000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2891000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2849000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15125000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11521000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2891000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2849000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15125000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11521000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2891000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2849000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15125000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11521000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	763000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2891000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2849000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15888000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11521000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18801754	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18801754	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16596333	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16596333	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18402919	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18402919	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16106528	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16106528	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5070000	usd
CY2022Q1	apcx	Common Stock Issued For Forbearance Amount CommonStockIssuedForForbearanceAmount	3000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2732000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13395000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	11104000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3602000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2120000	usd
CY2022Q2	apcx	Patent Acquisition Value PatentAcquisitionValue	407000	usd
CY2022Q2	apcx	Antidilution Provision Value AntidilutionProvisionValue	2123000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12152000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2849000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1450000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	10773000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7424000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3151000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	860000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	234000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4490000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9857000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-9083000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	813000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1587000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2891000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1285000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	153000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	667000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	816000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15125000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11521000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2958000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6052000	usd
	apcx	Common Stock Issued For Forbearances Two CommonStockIssuedForForbearancesTwo	-0	usd
	apcx	Common Stock Issued For Forbearances Two CommonStockIssuedForForbearancesTwo	-3000	usd
	apcx	Cancellation Of Stock Repurchase Liabilities CancellationOfStockRepurchaseLiabilities	430000	usd
	apcx	Cancellation Of Stock Repurchase Liabilities CancellationOfStockRepurchaseLiabilities	-0	usd
	apcx	Stock Issued For Excess Fair Value Of Equity Over Assets Received StockIssuedForExcessFairValueOfEquityOverAssetsReceived	0	usd
	apcx	Stock Issued For Excess Fair Value Of Equity Over Assets Received StockIssuedForExcessFairValueOfEquityOverAssetsReceived	904000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	49000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	712000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	6131000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	apcx	Gain On Settlement Of Derivative Liabilities GainOnSettlementOfDerivativeLiabilities	250000	usd
	apcx	Gain On Settlement Of Derivative Liabilities GainOnSettlementOfDerivativeLiabilities	-0	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-27000	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-181000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	202000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	58000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-614000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-66000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	205000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-872000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1685000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-190000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	557000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	apcx	Increase Decrease Right Of Use Asset And Liability IncreaseDecreaseRightOfUseAssetAndLiability	-7000	usd
	apcx	Increase Decrease Right Of Use Asset And Liability IncreaseDecreaseRightOfUseAssetAndLiability	1000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6545000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5747000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	50000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1748000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1748000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	88000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1021000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	50000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	679000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	5157000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	13395000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	20000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3384000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13365000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3211000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5870000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3462000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	251000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5878000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1233000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	apcx	Issuance Stock For Acquisition Of Intangible Assets IssuanceStockForAcquisitionOfIntangibleAssets	0	usd
	apcx	Issuance Stock For Acquisition Of Intangible Assets IssuanceStockForAcquisitionOfIntangibleAssets	407000	usd
	apcx	Cancellation Of Stock Repurchase Liability CancellationOfStockRepurchaseLiability	430000	usd
	apcx	Cancellation Of Stock Repurchase Liability CancellationOfStockRepurchaseLiability	0	usd
	apcx	Issuance Of Stock For Prepaid Services IssuanceOfStockForPrepaidServices	0	usd
	apcx	Issuance Of Stock For Prepaid Services IssuanceOfStockForPrepaidServices	250000	usd
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	9.5 to 1
CY2021Q4	apcx	Sale Of Stock Units SaleOfStockUnits	4.15
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zeLajt1da9se" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_865_ziqapxivLYxf">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated liabilities related to various vendors in which communications have ceased, contingent liabilities, and valuation of the derivative liabilities. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zbepc0oM24J4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i><span style="text-decoration: underline"><span id="xdx_862_zcTTCXo2Cwfb">Concentration of Credit Risk</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $250,000 per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounts receivable from merchant services are paid by the financial institutions on a monthly basis. <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zxE48KUmX7eg"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zZe1brmdLpCb">93</span></span>% of accounts receivable as of September 30, 2023 was from one customer, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zJVuGkXUrEWh">73</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zJmQrCzLYKec">12</span>% of accounts receivable as of December 31, 2022 was from two customers (85%).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months of September 30, 2023, two customers represented a significant amount of total revenue, at <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zj8fBLAXklc5">40</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zv5m1pW9dGS3">52</span>% respectively. For the three months of September 30, 2022, one customer representing a significant amount of total revenue at <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zOKhkU4mjb38">68</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the nine months of September 30, 2023 and September 30, 2022, two customers represented a significant amount of total revenue, at <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zae7Lk3lB1pf">61</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zYGx2nD9Kata">20</span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zV7SfrR4tpZ4">69</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zYYjyYO9FEvg">11</span>%, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3	apcx	Accrued Liabilities AccruedLiabilities	340000	usd
CY2022Q4	apcx	Accrued Liabilities AccruedLiabilities	1870000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8118273	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5999940	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8118273	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5999940	shares
CY2022Q4	apcx	Notes Payable Related Parties NotesPayableRelatedParties	88000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5200000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	900000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1800000	usd
CY2023Q3	apcx	Interest Payable InterestPayable	0	usd
CY2022Q4	apcx	Interest Payable InterestPayable	1436000	usd
CY2023Q3	apcx	Employee Related Liabilities EmployeeRelatedLiabilities	213000	usd
CY2022Q4	apcx	Employee Related Liabilities EmployeeRelatedLiabilities	311000	usd
CY2023Q3	apcx	Accrued Residuals AccruedResiduals	22000	usd
CY2022Q4	apcx	Accrued Residuals AccruedResiduals	31000	usd
CY2023Q3	apcx	Antidilution Provision Payable AntidilutionProvisionPayable	72000	usd
CY2022Q4	apcx	Antidilution Provision Payable AntidilutionProvisionPayable	72000	usd
CY2023Q3	apcx	Other Accrued Liabilities OtherAccruedLiabilities	33000	usd
CY2022Q4	apcx	Other Accrued Liabilities OtherAccruedLiabilities	20000	usd
	apcx	Derivative Loss On Derivative1 DerivativeLossOnDerivative1	390000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-27000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-166000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	433000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-27000	usd
	apcx	Extinguishment Of Derivative Liability ExtinguishmentOfDerivativeLiability	406000	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	90000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	120000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	110000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	55000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	64000	usd
CY2023Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	880000	usd
	apcx	Gain On Settlement Of Litigation Related To Convertible Note And Warrants GainOnSettlementOfLitigationRelatedToConvertibleNoteAndWarrants	250000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	763726	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1149000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1089868	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.00
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M28D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	763726	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.81
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10528	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.43
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	230526	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.21
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1612540	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M28D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1543448	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.30
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y7M28D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2500000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	122000	usd
	apcx	Share Based Compensation Modification Expense ShareBasedCompensationModificationExpense	711	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5823036	shares

Files In Submission

Name	View Source	Status
0001683168-23-008030-index-headers.html	Edgar Link	pending
0001683168-23-008030-index.html	Edgar Link	pending
0001683168-23-008030.txt	Edgar Link	pending
0001683168-23-008030-xbrl.zip	Edgar Link	pending
apcx-20230930.xsd	Edgar Link	pending
apptech_ex3101.htm	Edgar Link	pending
apptech_ex3102.htm	Edgar Link	pending
apptech_ex3201.htm	Edgar Link	pending
apptech_ex3202.htm	Edgar Link	pending
apptech_i10q-093023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
apcx-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
apptech_i10q-093023_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
apcx-20230930_def.xml	Edgar Link	unprocessable
apcx-20230930_pre.xml	Edgar Link	unprocessable
apcx-20230930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APCX
AppTech Payments Corp. Stock $apcx

2023 Q4 Form 10-Q Financial Statement

#000168316823008030 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APCX AppTech Payments Corp. Stock $apcx

2023 Q4 Form 10-Q Financial Statement

#000168316823008030 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APCX
AppTech Payments Corp. Stock $apcx